Facebook X (Twitter) Instagram
    Facebook Instagram Threads
    Global BiodefenseGlobal Biodefense
    Subscribe
    • Featured News
    • Funding
    • Directory
    • Jobs
    • Events
    Global BiodefenseGlobal Biodefense
    Industry News

    Next-Generation Ventilators Needed For Pandemics

    By Global Biodefense StaffSeptember 22, 2014
    Swine Flu H1N1 Pandemic Analysis
    Credit: Shutterstock, modified by Global Biodefense
    Share
    Facebook LinkedIn Reddit Email

    The U.S. Department of Health and Human Services (HHS) will sponsor the advanced development of a next-generation portable ventilator to help fill the need for portable, low-cost, user-friendly and flexible ventilators in a pandemic or other public health emergency.

    The new ventilator will be developed under a three year, $13.8 million contract with Philips Respironics of Murrysville, Pennsylvania.

    The project will be overseen by the Biomedical Advanced Research and Development Authority (BARDA) within the HHS Office of the Assistant Secretary for Preparedness and Response.

    “In pandemics and other emergencies, doctors must have medicines, vaccines, diagnostics, and critical equipment such as mechanical ventilators at the ready in order to save lives,” said BARDA Director Robin Robinson, Ph.D.

    In a severe influenza pandemic and potentially in other public health emergencies, a large number of severely ill patients would require mechanical ventilation. This number could overwhelm the capacity of the health care system to provide such care, both in the number of ventilators available and staff trained to operate them.

    The innovative ventilator in development will leverage advanced technology to reduce the size and cost and will be designed in a way that doctors, nurses and other health professionals can operate without special training. The next-generation ventilator also will be designed to be manufactured quickly to meet a surge in the number of patients who need ventilators if more ventilators are needed than could be stockpiled.

    The contract includes an option to purchase 10,000 completely kitted, initial production ventilators for $32.8 million.

    In addition to aiding in response to a public health emergency, the next-generation ventilator in development can have important implications for routine care. The modernized features, agility, and ease of use can improve patient care for triage in the field or advanced treatment in the hospital.

    Source: HHS press release, adapted.

    ASPR Awards BARDA HHS Pandemic
    Share. Facebook LinkedIn Reddit Email
    Previous ArticleFederal Contracts Roundup – Sep 22, 2014
    Next Article New DNA Sequencing Method to Diagnose Tuberculosis

    Related Stories

    Jurata Thin Film and CastleVax Awarded Grant to Advance Thermostabilized COVID-19 Booster

    September 20, 2023

    Mount Sinai to Lead Development of Pan-Coronavirus Vaccine Under New Federal Grant

    September 17, 2023

    Smallpox Vaccines: Bavarian Nordic Awarded Another Contract to Supply EU Strategic Reserve

    September 13, 2023

    HHS Extends Partnership with Regeneron to Develop Life-Saving Monoclonal Antibodies

    September 8, 2023
    News Scan

    Biodefense Headlines – 19 September 2023

    News Scan September 19, 2023

    News highlights on health security threats and countermeasures curated by Global Biodefense This week’s selections include a global survey of gain-of-function research; funding of an mRNA mpox vaccine; Nipah virus outbreak in India; field detection of threat agents with acoustic…

    Upcoming Events

    Oct 3
    Virtual Event Virtual Event
    October 3 - October 5

    OneLab Summit 2023

    Oct 3
    Virtual Event Virtual Event
    12:00 pm - 2:00 pm EDT

    Public-Private Partnerships to Distribute, Dispense, and Administer Medical Countermeasures

    Oct 4
    Virtual Event Virtual Event
    10:00 am - 2:00 pm EDT

    Tunneling Nanotubes and Intracellular Protrusions Workshop

    Oct 12
    Virtual Event Virtual Event
    12:00 pm - 2:00 pm EDT

    Public-Private Partnerships for Acceptance and Uptake of Medical Countermeasures

    View Calendar

    Subscribe to Global Biodefense

    Get the latest news on pathogens and preparedness

    © 2023 Stemar Media Group LLC
    • About
    • Contact
    • Privacy
    • Subscribe

    Type above and press Enter to search. Press Esc to cancel.

    We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are okay with it.OkPrivacy policy